1 Oct 2026, 16:36
Securities Administration—
RCERECCE PHARMACEUTICALS LTD
Announcement history available from 1 August 2025
Fromto
29 Sept 2026, 16:47
Meetings & Governance—
18 Sept 2026, 16:10
Meetings & Governance—
2 Sept 2026, 13:12
Meetings & Governance—
2 Sept 2026, 10:01
Presentations—
31 Aug 2026, 19:28
Company Administration—
31 Aug 2026, 19:16
Financial ResultsMS
19 Aug 2026, 11:02
Company UpdateMS
6 Aug 2026, 16:55
Director Interests—
4 Aug 2026, 16:12
Securities Administration—
3 Aug 2026, 08:23
Securities Administration—
31 July 2026, 11:32
Capital Raising—
31 July 2026, 11:30
Securities Administration—
31 July 2026, 09:04
Meetings & Governance—
30 July 2026, 10:38
Company Update—
21 July 2026, 12:50
Presentations—
21 July 2026, 12:27
Presentations—
21 July 2026, 12:20
Quarterly ReportsMS
20 July 2026, 09:33
Securities Administration—
20 July 2026, 09:29
Capital Raising—
14 July 2026, 08:56
Company UpdateMS
6 July 2026, 09:06
Capital Raising—
3 July 2026, 14:31
Securities Administration—
3 July 2026, 14:25
Securities Administration—
2 July 2026, 16:26
Securities Administration—
1 July 2026, 11:30
Securities Administration—
1 July 2026, 11:24
Securities Administration—
1 July 2026, 11:10
Securities Administration—
1 July 2026, 11:04
Securities Administration—
1 July 2026, 09:07
Company UpdateMS
26 June 2026, 18:00
Securities Administration—
26 June 2026, 10:35
Presentations—
26 June 2026, 10:19
Securities Administration—
26 June 2026, 10:03
Capital RaisingMS
24 June 2026, 10:08
Trading Halt / SuspensionMS
24 June 2026, 09:54
Trading Halt / SuspensionMS
22 June 2026, 10:03
Company UpdateMS
27 May 2026, 13:49
Company UpdateMS
27 May 2026, 09:48
Company UpdateMS
30 Apr 2026, 17:03
Quarterly ReportsMS
21 Apr 2026, 10:52
Company Update—
15 Apr 2026, 17:28
Securities Administration—
24 Mar 2026, 11:52
Company UpdateMS
19 Mar 2026, 10:43
PresentationsMS
17 Mar 2026, 15:00
Presentations—
27 Feb 2026, 18:02
Financial ResultsMS
24 Feb 2026, 17:51
Director Interests—
24 Feb 2026, 17:17
Securities Administration—
2 Feb 2026, 08:58
Company UpdateMS
30 Jan 2026, 13:01
Quarterly ReportsMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 1 Oct 2026, 16:36 | Notification of cessation of securities - RCE | Securities Administration | — | 06027 | |
| 29 Sept 2026, 16:47 | Resolutions under section 249N of the Corporations Act | Meetings & Governance | — | 08006 | |
| 18 Sept 2026, 16:10 | 2026 Annual General Meeting | Meetings & Governance | — | 08006 | |
| 2 Sept 2026, 13:12 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 2 Sept 2026, 10:01 | General Meeting Presentation | Presentations | — | 03026, 15002 | |
| 31 Aug 2026, 19:28 | Appendix 4G | Company Administration | — | 03025 | |
| 31 Aug 2026, 19:16 | Appendix 4E and FY26 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020, 03024 | |
| 19 Aug 2026, 11:02 | HREC Approves Comparator Study for Pivotal Phase 3 DFI | Company Update | MS | 11001 | |
| 6 Aug 2026, 16:55 | Change of Director's Interest Notices (x4) | Director Interests | — | 02009 | |
| 4 Aug 2026, 16:12 | Cleansing Notice | Securities Administration | — | 06018 | |
| 3 Aug 2026, 08:23 | Application for quotation of securities - RCE | Securities Administration | — | 06020 | |
| 31 July 2026, 11:32 | Completion of Share Purchase Plan and Shortfall Notice | Capital Raising | — | 06017 | |
| 31 July 2026, 11:30 | Application for quotation of securities - RCE | Securities Administration | — | 06020 | |
| 31 July 2026, 09:04 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 30 July 2026, 10:38 | U.S. Government Releases US$66.9B AMR Biodefense Strategy | Company Update | — | 11001 | |
| 21 July 2026, 12:50 | Investor Webinar - Q4 FY26 Investor Presentation Deck | Presentations | — | 03026, 19009 | |
| 21 July 2026, 12:27 | Investor Webinar - 2.30PM (AEST) 21 July 2026 | Presentations | — | 14014 | |
| 21 July 2026, 12:20 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 20 July 2026, 09:33 | Update - Proposed issue of securities - RCE | Securities Administration | — | 06013 | |
| 20 July 2026, 09:29 | Extension to Share Purchase Plan Closing Date | Capital Raising | — | 06017 | |
| 14 July 2026, 08:56 | Vietnamese Patent Granted for RECCE Anti-Infectives | Company Update | MS | 11001 | |
| 6 July 2026, 09:06 | Share Purchase Plan - Letter and Offer Booklet | Capital Raising | — | 06017, 16002 | |
| 3 July 2026, 14:31 | Cleansing Notice | Securities Administration | — | 06018 | |
| 3 July 2026, 14:25 | Application for quotation of securities - RCE | Securities Administration | — | 06020 | |
| 2 July 2026, 16:26 | Notification of cessation of securities - RCE | Securities Administration | — | 06027 | |
| 1 July 2026, 11:30 | Cleansing Notice | Securities Administration | — | 06018 | |
| 1 July 2026, 11:24 | Application for quotation of securities - RCE | Securities Administration | — | 06020 | |
| 1 July 2026, 11:10 | Application for quotation of securities - RCE | Securities Administration | — | 06020 | |
| 1 July 2026, 11:04 | Application for quotation of securities - RCE | Securities Administration | — | 06020 | |
| 1 July 2026, 09:07 | AUD $3.7M Income Tax Refund Received | Company Update | MS | 11001, 12008 | |
| 26 June 2026, 18:00 | Proposed issue of securities - RCE | Securities Administration | — | 06013 | |
| 26 June 2026, 10:35 | RCE Investor Presentation | Presentations | — | 03026 | |
| 26 June 2026, 10:19 | Proposed issue of securities - RCE | Securities Administration | — | 06013 | |
| 26 June 2026, 10:03 | Placement & SPP to raise $8 million | Capital Raising | MS | 06003, 06017, 09014 | |
| 24 June 2026, 10:08 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 24 June 2026, 09:54 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 22 June 2026, 10:03 | HREC Approval Accelerates Global Phase 3 DFI Strategy | Company Update | MS | 11001 | |
| 27 May 2026, 13:49 | Addendum to Recce Signs Middle East Licensing Term Sheet | Company Update | MS | 11001 | |
| 27 May 2026, 09:48 | Recce Signs Middle East Licensing Term Sheet | Company Update | MS | 11001 | |
| 30 Apr 2026, 17:03 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 21 Apr 2026, 10:52 | Positive Regulatory Inspection Outcome for Phase 3 Trial | Company Update | — | 11001 | |
| 15 Apr 2026, 17:28 | Notification of cessation of securities - RCE | Securities Administration | — | 06027 | |
| 24 Mar 2026, 11:52 | Brazil Patent Granted for RECCE Anti-Infectives | Company Update | MS | 11001 | |
| 19 Mar 2026, 10:43 | RCE Investor Webinar Presentation Deck | Presentations | MS | 03026 | |
| 17 Mar 2026, 15:00 | RCE Investor Webinar Presentation | Presentations | — | 14014 | |
| 27 Feb 2026, 18:02 | Appendix 4D and Interim Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 24 Feb 2026, 17:51 | Change of Director's Interest Notices (x5) | Director Interests | — | 02009 | |
| 24 Feb 2026, 17:17 | Notification of cessation of securities - RCE | Securities Administration | — | 06027 | |
| 2 Feb 2026, 08:58 | Recce Enters Second U.S. Department of Defense R&D Agreement | Company Update | MS | 11001 | |
| 30 Jan 2026, 13:01 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 |
1–50 of 70
1 / 2